Neurofenix London
Entrepreneur First '16London, GB · Founded 2016 · 6 employees on LinkedIn · 4 known investors
Find your way into Neurofenix London
350 people in our graph share verified history with the Neurofenix London team — schools, employers, funds. One of them is your warm intro.
Neurofenix develops neuro-rehabilitation technology and delivers virtual in-home therapy services for people recovering from neurological conditions such as stroke. Its offering combines occupational and clinical therapy with its own rehabilitation platform.
Also known as Neurofenix
Founders & leadership
Neurofenix London was founded in 2016 by Guillem Buxarrais and Dimitris Athanasiou.
Investors · 4
Company profile
researched Aug 2026Neurofenix is a virtual care provider focused on neurological rehabilitation delivered in patients' homes. Its model pairs each patient with a dedicated therapist and an expert clinical team, who design personalized weekly therapy plans intended to deliver high-dose, high-repetition, high-intensity full-body therapy. The company positions its approach as grounded in neuroplasticity principles, using gamified therapy sessions, remote monitoring and messaging to sustain patient engagement and habit formation between sessions.
A flagship offering is an Upper Limb Stroke Program aimed at stroke survivors and their caregivers, referenced on the company website alongside the NeuroBall device mentioned in patient testimonials. Supporting technology includes remote tracking devices that report real-time usage data and the NeuroPlatform and accompanying dashboard, which clinicians use to monitor patient progress. The company states that it produces HIPAA-compliant reports, evaluations and monitoring outputs to support clinical decision-making and documentation.
Neurofenix markets itself to healthcare organizations as an extension of existing care pathways, offering same-day patient enrollment, updates on enrollment status and progress, and a 24/7 contact line (1-800-945-8132). The website references accreditations and collaborations without detailing them in the retrieved material.
Business model
Neurofenix delivers therapy services virtually, combining clinician labor (a dedicated therapist and clinical team) with proprietary hardware and software. It invites healthcare providers to partner with it to add virtual care services for their neurological patients, while also addressing stroke survivors and caregivers directly.
Traction
Evidence in the retrieved sources is limited to patient testimonials on the company website describing functional gains such as improved use of the hand and arm and greater training duration. No user counts, revenue, contract or outcome statistics are disclosed.
Latest developments
No dated news, funding or product announcements about Neurofenix appear in the retrieved sources; the only company-specific material is its current website.
▸Full profile — market position, technology, go-to-market, geography
Market position
The company frames its market opportunity around access gaps, stating that 70% of Americans lack access to neuro rehabilitation because of factors such as few locations, transportation, high out-of-pocket costs, long waitlists and cultural barriers, and positions its virtual care model as removing those barriers. The retrieved sources contain no competitive comparisons or market-share data.
Technology
The stack comprises remote tracking devices that stream real-time usage data, gamified therapeutic activities performed at home (patient testimonials cite the NeuroBall for hand and arm movement), and the NeuroPlatform with a monitoring dashboard used to track patient progress. Outputs include HIPAA-compliant reports, evaluations and monitoring records, and the company says its approach integrates with existing healthcare systems and care pathways.
Go-to-market
Two-sided outreach: a partnership motion toward clinicians and healthcare organizations that can refer neurological patients, supported by same-day enrollment, progress reporting and a 24/7 contact line; and a direct-to-patient motion addressing stroke survivors and caregivers through the website, testimonials and 'let's talk' contact prompts.
Neurological patients rehabilitating at home, particularly stroke survivors and their caregivers, and the healthcare providers and organizations that refer or manage such patients and wish to extend rehabilitation services into the home.
Geography
Internal records place the headquarters in London, United Kingdom. Public-facing material is US-oriented, citing a US toll-free contact number, HIPAA-compliant documentation and access statistics for Americans.
Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 3
primary sources listed
- Neurofenix Londonneurofenix.com · web
3 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Neurofenix London do?
- Neurofenix is a tech-enabled virtual care provider delivering at-home neurological rehabilitation with dedicated therapists.
- Who founded Neurofenix London?
- Neurofenix London was founded by Guillem Buxarrais, Dimitris Athanasiou in 2016.
- Who are Neurofenix London's investors?
- Neurofenix London's investors include AlbionVC, Entrepreneur First, InHealth Ventures, Oxford Investment Opportunity Network (OION).
- Where is Neurofenix London headquartered?
- Neurofenix London is headquartered in London, GB.